thank you!
obvious
watch it is.
post working?
good point
also says drug will be used for many unmet medical diseases
Seeking Alpha Market Currents 4/19/13
Canaccord says "the CF corrector discovery platform" has been validated and the "likelihood for trial success and uptake" has increased. Canaccord raises target to $96
2nnd led up folks.
love Needham.
yeah baby $$
very good article.
2nd leg coming folks going higher
AA soon.